Bravida (BRAV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
29 May, 2026Executive summary
EBITA/EBITDA increased to SEK 342 million with a margin of 5.3%, up from 4.5% year-over-year, mainly due to strong performance in Denmark, despite a 2.2% decline in net sales and negative organic growth of 3%.
EPS rose by 24% year-over-year, driven by margin improvements and strict project selection.
Order intake grew 5% year-over-year, with backlog stable and quality of orders improved, particularly in Sweden and Finland.
Acquisitions contributed to growth, with two completed by Q3 and additional deals in Q4, adding over SEK 391 million in annual sales.
CO2 emissions per net sales down 42% since 2020, with LTIFR improved to 5.0.
Financial highlights
Net sales declined by 2.2% year-over-year to SEK 6,433 million, mainly due to selective project intake and market softness.
EBITA/EBITDA margin improved to 5.3% from 4.5% year-over-year, driven by Denmark's performance.
Operating cash flow was negative SEK 111 million in Q3, with cash conversion at 63% versus 134% last year, due to timing of large project invoicing.
Net debt stood at SEK 3,469 million, with net debt/EBITDA at 1.5x, below the 2.5x target.
Dividend payout ratio was 73%, above the >50% target.
Outlook and guidance
Full-year margin guidance remains close to 5%, with management confident in achieving this.
Market is expected to remain challenging into 2026, with stable service demand but unpredictable installation demand.
Service activity stable; installation business faces challenges but infrastructure, industry, and defense projects offer opportunities.
Continued focus on selective project strategy and cost control, prioritizing margin over volume.
External forecasts suggest installation market growth in 2026 and 2027, but current order intake does not yet reflect this.
Latest events from Bravida
- Flat sales, lower EBITA, and strong cash flow as service growth offsets market and restructuring headwinds.BRAV
Q3 20241 Jun 2026 - Net sales and EBITA rose, order backlog strengthened, and a SEK 100m share buyback was launched.BRAV
Q1 20265 May 2026 - EBITA margin and EPS rose in Q4, with strong cash flow and a higher dividend proposed.BRAV
Q4 202511 Apr 2026 - Flat sales, improved margins, strong cash flow, and higher dividend despite market headwinds.BRAV
Q4 202418 Feb 2026 - Q2 sales up 5%, margin down to 4.5%, but cash flow and backlog strong; margin recovery expected.BRAV
Q2 20243 Feb 2026 - EBITA margin rose to 4.5% as profit grew despite lower sales and market uncertainty.BRAV
Q1 202517 Nov 2025 - EBITA margin rose to 5.4% and order intake increased 9% despite a 9% sales decline.BRAV
Q2 202513 Nov 2025